Uniphos Enterprises Q2 FY27: Total income Rs 25.19 cr, PAT Rs 22.22 cr
Standalone Q2 FY27 total income was Rs 25.19 cr and PAT Rs 22.22 cr, versus Rs 24.43 cr and Rs 23.16 cr a year earlier.
Key takeaways
- Total income Rs 25.19 cr in Q2 FY27 vs Rs 24.43 cr in Q2 FY26
- PAT Rs 22.22 cr in Q2 FY27 vs Rs 23.16 cr in Q2 FY26
- Total expenses Rs 2.97 cr in Q2 FY27 vs Rs 1.27 cr in Q2 FY26
- Other Comprehensive Loss Rs 100.72 cr in Q2 FY27 vs profit Rs 4.91 cr in Q2 FY26
- Total comprehensive loss Rs 78.50 cr in Q2 FY27 vs profit Rs 28.07 cr in Q2 FY26
Q2 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | - | - | 0.0% |
| PAT | Rs 22.22 cr | Rs 23.16 cr | -4.0% |
As reported in the filing. Figures are transcribed, not computed.
Key numbers (standalone)
From the statement of unaudited financial results for the quarter ended 30 September 2026 (Q2 FY27), compared with the quarter ended 30 September 2025:
- Total income: Rs 25.19 cr (Q2 FY26: Rs 24.43 cr)
- Revenue from operations: - (Q2 FY26: -)
- Other income: Rs 25.19 cr (Q2 FY26: Rs 24.43 cr)
- Total expenses: Rs 2.97 cr (Q2 FY26: Rs 1.27 cr)
- Employee benefits expense: Rs 2.30 cr (Q2 FY26: Rs 0.3406 cr)
- Depreciation and amortisation expenses: Rs 0.1565 cr (Q2 FY26: Rs 0.171 cr)
- Other expenses: Rs 0.5157 cr (Q2 FY26: Rs 0.7541 cr)
- Profit/(Loss) from operations before tax (PBT): Rs 22.22 cr (Q2 FY26: Rs 23.16 cr)
- Net Profit/(Loss) for the period (PAT): Rs 22.22 cr (Q2 FY26: Rs 23.16 cr)
- Other Comprehensive (Loss)/Profit: (Rs 100.72 cr) (Q2 FY26: Rs 4.91 cr)
- Total Comprehensive (Loss)/Profit for the period: (Rs 78.50 cr) (Q2 FY26: Rs 28.07 cr)
- Paid-up equity share capital: Rs 13.91 cr (Q2 FY26: Rs 13.91 cr)
- Earnings Per Share (Basic): Rs 3.19 (Q2 FY26: Rs 3.33)
- Earnings Per Share (Diluted): Rs 3.19 (Q2 FY26: Rs 3.33)
For the half year ended 30 September 2026, compared with the half year ended 30 September 2025:
- Total income: Rs 25.36 cr (H1 FY26: Rs 30.55 cr)
- Revenue from operations: - (H1 FY26: Rs 5.86 cr)
- Other income: Rs 25.36 cr (H1 FY26: Rs 24.69 cr)
- Total expenses: Rs 4.32 cr (H1 FY26: Rs 8.13 cr)
- Employee benefits expense: Rs 2.80 cr (H1 FY26: Rs 0.6877 cr)
- Depreciation and amortisation expenses: Rs 0.3116 cr (H1 FY26: Rs 0.3421 cr)
- Other expenses: Rs 1.21 cr (H1 FY26: Rs 1.30 cr)
- Profit/(Loss) from operations before tax (PBT): Rs 21.03 cr (H1 FY26: Rs 22.42 cr)
- Net Profit/(Loss) for the period (PAT): Rs 21.03 cr (H1 FY26: Rs 22.42 cr)
- Other Comprehensive (Loss)/Profit: (Rs 86.68 cr) (H1 FY26: Rs 83.83 cr)
- Total Comprehensive (Loss)/Profit for the period: (Rs 65.65 cr) (H1 FY26: Rs 106.25 cr)
According to the statement of financial results, Uniphos Enterprises Limited continued to report its income almost entirely as "Other Income" in Q2 FY27, with no revenue from operations disclosed for the quarter, similar to the corresponding quarter of the previous year. Total income for Q2 FY27 was slightly higher than a year earlier, while total expenses also increased, mainly due to higher employee benefits expense.
Profit before tax and net profit for Q2 FY27 were lower than the corresponding quarter a year earlier, as shown in the profit from operations before tax and net profit lines in the statement of financial results. The company also reported a sizeable negative figure under Other Comprehensive (Loss)/Profit for Q2 FY27, which resulted in a total comprehensive loss for the quarter, compared with a total comprehensive profit in the same quarter of the previous year.
Track Uniphos Enterprises Ltd
Cruxal reads every Uniphos Enterprises Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
